Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Circulatory system drugs>Angina Pectoris Drugs>Nifedipine
Nifedipine
  • Nifedipine
  • Nifedipine
  • Nifedipine
  • Nifedipine
  • Nifedipine

Nifedipine NEW

Price Get Latest Price
Package 1kg
Min. Order: 1kg
Supply Ability: 10000kg
Update Time: 2024-05-09

Product Details

Product Name: Nifedipine CAS No.: 21829-25-4
EC-No.: 244-598-3 Min. Order: 1kg
Purity: 99% Supply Ability: 10000kg
Release date: 2024/05/09

Factory Provide Pharmaceutical Raws 99.9% Powder CAS 21829-25-4 Nifedipine


Article illustration

Introduction

Product Name : Nifedipine

Other name: 1,4-Dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl;Nifedipine,1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester

CAS No.: 21829-25-4

MF:C17H18N2O6

MW:346.33

Appearance: Yellow powder 

Melting Point :171-175 °C

Boiling Point :481.08°C (rough estimate)

Density :1.2109 (rough estimate)

Storage :Sealed in dry,Sealed in dry,Room Temperature


Nifedipine, also known as 1, 4-dihydro-2, 6-dimethyl-4 -(2-nitrophenyl)-3, 5-pyridine dicarboxylate, is a dihydropyridine calcium antagonist used for the prevention and treatment of coronary heart disease angina pectoris, especially variant angina pectoris and angina pectoris caused by coronary artery spasms.It has no adverse effect on respiratory function, so it is suitable for patients with angina pectoris suffering from respiratory obstructive diseases, and its efficacy is better than that of β-receptor antagonists.It is also applicable to various types of hypertension, and has a good effect on intractable and severe hypertension.Because it can reduce afterload, it also has a good effect on refractory congestive heart failure, and is suitable for long-term use.


Application 

It is used to prevent and treat angina pectoris caused by coronary heart disease, especially variant angina pectoris and coronary artery spasm. It has no adverse effect on respiratory function, so it is suitable for patients with angina pectoris suffering from respiratory obstructive disease, and its efficacy is better than that of β-receptor antagonists. It is also suitable for various types of hypertension, and has a good effect on refractory and severe hypertension. Because it can reduce afterload, it also has good effect on refractory congestive heart failure and is suitable for long-term use.


Article illustration



Company Profile Introduction

Shaanxi TNJONE Pharmaceutical Co., Ltd supplies more than 2,000 kinds of products, covering the whole field of health industry, including human APIs, veterinary APIs, food additives, natural nutrition ingredients, feed additives, cosmetic additives, intermediates etc. With global sourcing advantages, the group is fully capable of meeting the one-stop sourcing needs of global customers. Today, Shaanxi TNJONE Pharmaceutical Co., Ltd.'s marketing network has spread over more than 100 countries and regions on five continents, providing professional service for global customers.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1kg
VIP3Y
Sinoway Industrial co., ltd.
2024-05-15
$0.00/25kg
VIP1Y
PUSHAN INDUSTRIAL (SHAANXI) CO.,LTD
2024-05-15
$30.00/1kg
VIP1Y
Ouhuang Engineering Materials (Hubei) Co., Ltd
2024-04-18
$80.00/1kg
VIP1Y
Liaoning Pharmaceutical Innovation Co., Ltd
2024-03-08
$100.00/1kg
Henan Bao Enluo International TradeCo.,LTD
2023-08-21
$100.00/25kg
VIP4Y
Hebei Mojin Biotechnology Co., Ltd
2022-06-28
$350.00/1KG
VIP4Y
Hebei Lingding Biotechnology Co., Ltd.
2021-10-27
$0.00/1ASSAYS
Jiangsu Monade Biological Technology Co., Ltd.
2021-09-10
$1.90/1KG
VIP4Y
Hebei Guanlang Biotechnology Co,.LTD
2021-08-25
$1.10/1g
VIP4Y
Dideu Industries Group Limited
2021-08-06

Shaanxi TNJONE Pharmaceutical Co., Ltd

1YR ChinaChina
  • Since: 2019-05-23
  • Address: No. 4C-11-A392, Financial Port, Northwest corner of Fengjing Avenue and Fengxin Road, Fengdong New C
INQUIRY